Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
51.32M
Enterprise Value
138.91M
Income
-59.43M
Sales
435.88M
Book/sh
-0.58
Cash/sh
0.00
Employees
300
IPO
Aug 27, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
0.12
P/B
-
P/C
641.55
P/FCF
-
EV/EBITDA
-
EV/Sales
0.32
Quick Ratio
0.71
Current Ratio
0.71
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-1.08
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
57.16% 21.24%
Sales past 3/5Y
1669.59% 321.02%
EPS Y/Y TTM
82.80%
Sales Y/Y TTM
27.45%
EPS Q/Q
62.29%
Sales Q/Q
-7.33%
Insider Own
68.00%
Insider Trans
-0.56%
Inst Own
3.36%
Inst Trans
16.58%
ROA
-49.61%
ROE
-4295.48%
ROIC
-
Gross Margin
9.42%
Oper. Margin
-11.52%
Profit Margin
-13.63%
SMA20
-18.68%
SMA50
-46.81%
SMA200
-73.53%
Trades
Shs Outstand
55.71M
Shs Float
26.01M
52W High
5.25 -87.97%
52W Low
0.41 52.59%
Volatility
19.52% 35.94%
ATR (14)
0.27
RSI (14)
41.99
Beta
0.80
Rel Volume
0.20
Avg Volume
10.50M
Volume
2,055,026
Perf Week
-45.10%
Perf Month
-51.43%
Perf Quarter
-81.10%
Perf Half Y
-69.05%
Perf YTD
-52.53%
Perf Year
-67.11%
Perf 3Y
-96.18%
Perf 5Y
-
Perf 10Y
-
Prev Close
0.74
Price
0.63
Change
-14.69%
Jul-01-26 08:00AM
Jun-30-26 08:00AM
Jun-25-26 08:00AM
Jun-23-26 11:01AM
08:00AM
08:27AM Loading…
Jun-22-26 08:27AM
Jun-02-26 05:00PM
May-06-26 08:00AM
Apr-30-26 08:00AM
Apr-28-26 08:00AM
Apr-16-26 08:00AM
Mar-27-26 08:05AM
Mar-16-26 08:30AM
Feb-24-26 01:10PM
Feb-17-26 08:30AM
04:05PM Loading…
Feb-02-26 04:05PM
Jan-23-26 10:16AM
08:00AM
Nov-24-25 09:47AM
Nov-17-25 07:30AM
Oct-06-25 08:30AM
Sep-25-25 08:00AM
Sep-15-25 11:00AM
Aug-18-25 07:00AM
Aug-14-25 07:00AM
Jul-18-25 05:30PM
Jun-17-25 09:01AM
Jun-05-25 12:00PM
Jun-02-25 01:05PM
May-29-25 11:32PM
12:51PM Loading…
12:51PM
Mar-28-25 07:30AM
Mar-06-25 12:00PM
Feb-10-25 07:00AM
Jan-15-25 08:20AM
Jan-14-25 08:00AM
Dec-10-24 04:01PM
Nov-25-24 08:00AM
Nov-14-24 08:00AM
Nov-04-24 07:30AM
Oct-23-24 03:06PM
Oct-09-24 01:11PM
Circle8 Group, Inc. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones on April 1, 2014 and is headquartered in Englewood Cliffs, NJ.
CEOGuus Franke
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Franke Guus Paul WilhelmChairman & CEOJul 01 '26Sale1.00308,783308,78312,207,287Jul 07 08:00 PM
PFEFFER DAVIDDirectorMar 12 '26Option Exercise0.00161,2900162,820Mar 16 06:42 PM
Bressman Andrew10% OwnerJan 05 '26Option Exercise1.33500,000665,0007,003,971Jan 07 05:34 PM
Tenore MichaelGeneral CounselJan 07 '26Option Exercise1.331,202,9011,599,8581,843,725Jan 07 04:49 PM
Jagid Jeffrey MChief Executive OfficerJan 01 '26Option Exercise1.335,551,2237,383,1278,221,025Jan 05 05:12 PM
Tenore MichaelGeneral CounselJan 01 '26Option Exercise1.33264,860352,2641,266,554Jan 05 04:22 PM